Relationship between long-acting reversible contraception and acne in a cohort of adolescents and young adults

被引:1
作者
Boos, Markus D. [1 ,2 ,8 ]
Ryan, Morgan E. [3 ]
Milliren, Carly [3 ]
Golub, Sarah [4 ]
Maslyanskaya, Sofya [5 ]
Escovedo, Michelle [6 ]
Divasta, Amy [7 ]
Pitts, Sarah [7 ]
机构
[1] Univ Washington, Sch Med, Dept Pediat, Div Dermatol, Seattle, WA USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA
[4] Univ Washington, Seattle Childrens Hosp, Sch Med, Dept Pediat, Seattle, WA USA
[5] Childrens Hosp Montefiore, Div Adolescent Med, New York, NY USA
[6] Childrens Hosp Los Angeles, Div Adolescent Young Adult Med, Los Angeles, CA USA
[7] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA
[8] Seattle Childrens Hosp, Dept Surg, 4800 Sand Point Way NE,OC9 833, Seattle, WA 98105 USA
关键词
acne; adolescence; long-acting reversible contraception; progestin;
D O I
10.1111/pde.15578
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThe use of progestin-only long-acting reversible contraception (LARC) may be a risk factor for acne. Few studies have focused primarily on the effects of hormonal LARC on the development or exacerbation of acne in adolescents and young adults. We sought to understand the incidence and management of acne following hormonal LARC insertion in this adolescent/young adult population.MethodsA secondary data analysis was conducted of prospectively collected quality improvement (QI) data from the Adolescent Medicine LARC Collaborative. Subjects were evaluated by clinicians in adolescent medicine clinics at participating study sites, and acne severity was documented using a standardized recording instrument and scale. Descriptive statistics were reported as frequencies and percentages for categorical variables or mean and standard deviation (SD) for continuous variables. We compared demographic and clinical characteristics by those who had worsening acne, accounting for site inter-correlation using Cochran-Mantel-Haenszel chi-square tests for categorical variables and linear generalized estimating equation (GEE) regression for continuous variables.ResultsOf 1319 subjects who completed LARC insertion, 28.5% (376/1319) experienced worsening acne following use of progestin-only LARC. Acne was a contributing factor to LARC removal in only 3% (40/1319), and the sole reason for removal in 0.4% (5/1319) of all subjects. As this was a secondary analysis of prospectively collected QI data, limitations of this study include incomplete or inaccurate documentation of acne severity. Moreover, LARC insertions without follow-up/removal visits or with only follow-up/removal within 8 weeks of insertion were excluded from our study, which may also bias results.ConclusionsAdolescents and young adults seeking progestin-only LARC should be counseled about the potential for developing acne or experiencing a worsening of existing acne during LARC use. However, acne was not a common reason for LARC discontinuation.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [41] Availability of Long-Acting Reversible Contraception in Kansas Health Departments
    Evans, Tawana
    Ramaswamy, Megha
    Satterwhite, Catherine L.
    JOURNAL OF RURAL HEALTH, 2018, 34 (02) : 132 - 137
  • [42] Chlamydia testing and diagnosis following initiation of long-acting reversible contraception: A retrospective cohort study
    Rose, Sally B.
    Garrett, Susan M.
    Stanley, James
    Pullon, Susan R. H.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2017, 57 (06) : 665 - 675
  • [43] Long-acting reversible contraception: A route to reproductive justice or injustice
    Kaitz, Marsha
    Mankuta, David
    Mankuta, Lihi
    INFANT MENTAL HEALTH JOURNAL, 2019, 40 (05) : 673 - 689
  • [44] Preconception counselling at long-acting reversible contraception (LARC) removals
    Blake, Georgina
    Thomas, Helen
    Stephenson, Judith M.
    D'Souza, Rachel
    Hall, Jennifer Anne
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2024,
  • [45] Recent progress in advanced biomaterials for long-acting reversible contraception
    Yan, Mingzhe
    Zhang, Yanming
    Wu, Zhihang
    Li, Yifei
    Dou, Keke
    Wang, Banghui
    Wang, Yingruo
    Zhou, Qihui
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [46] Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study
    Bryson, Amanda E.
    Cabral, Howard J.
    Coles, Mandy S.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2021, 34 (04) : 525 - 529
  • [47] Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals
    Wu, Min
    Eisenberg, Ruth
    Negassa, Abdissa
    Levi, Erika
    CONTRACEPTION, 2020, 102 (06) : 409 - 413
  • [48] The relationship between area deprivation and prescription of long-acting reversible contraception in women of reproductive age in Lothian, Scotland, UK
    Morgan, Catherine Rachel
    Liu, Hanhua
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2017, 43 (04) : 281 - 288
  • [49] Making Contraception Accessible Through Implementation of Immediate Postpartum Long-Acting Reversible Contraception
    Fenner, Tania
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2019, 48 (03): : S12 - S13
  • [50] Cost Savings and Effectiveness of Long-Acting Reversible Contraception (LARC) on the Prevention of Pregnancy in Adolescents: A Systematic Review
    Marmett, Bruna
    Guaranha, Daniela Dal Forno Kinalski
    de Carvalho, Amanda Ferreira
    Reis, Julia Mathias
    de Souza, Carmem Lisiane Escouto
    Dalcin, Tiago Chagas
    Amantea, Sergio Luis
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2024, 37 (01) : 11 - 17